{"i": ["etonogestrel ( or 3 - ketodesogestrel )", "desogestrel combined with 30 \u03bcg of ethinyl estradiol", "Desogestrel", "mini - pill \"", "Etonogestrel", "Levonorgestrel", "oral contraceptives", "etonogestrel or 3 - ketodesogestrel ).", "smoking or xanthine - containing drinks consuming ( including coffee and tea )", "Cerazette \u00ae", "Liseta \u00ae,", "ethinyl estradiol and desogestrel .", "progestins", "estrogens", "venous catheter", "etonogestrel ( or 3 - ketodesogestrel ),", "progesterone", "levonorgestrel", "3 - ketodesogestrel", "generic oral contraceptives", "ethinyl estradiol .", "desogestrel .", "etonogestrel", "desogestrel", "branded oral contraceptives", "Traditional progestogen - only pills", "progestogen", "levonorgestrel )", "etonogestrel or 3 - ketodesogestrel", "desogestrel ),", "3 - ketodesogestrel )", "physiological saline serum", "combined oral contraceptives", "3 - Ketodesogestrel", "ethinyl estradiol", "etonogestrel combined with 30 \u03bcg of ethinyl estradiol .", "Cerazet \u00ae", "mini - pill desogestrel (\" progestogen - only mini - pill \")"], "o": ["ovulation", "serious adverse events", "ratio of Cmax", "AUC0 \u2013 t", "AUC", "systemic bioavailability and the tolerability", "side - effects", "sperm penetration .", "parameter Cmax", "tolerability .", "bioavailability", "within - run accuracy", "central nervous ( headache ) and genitourinary systems ( polymenorrhoea and dysmenorrhoea", "irregular bleeding", "linearity , quantification limit , precision , accuracy , selectivity , matrix effect , dilution effect , recovery and stability .", "body weight and height", "parameters Cmax and AUC0 \u2013 t", "maximum serum levels", "extent of follicular development", "analytical tolerability ( blood biochemistry , haematological and urinary analysis", "bleeding pattern", "viscosity of the cervical mucus", "plasma level", "mean bioavailability", "menstrual side effects", "bioequivalence and tolerability", "Plasma concentration - time curves", "Positive ions", "irregular menstrual bleeding .", "Pharmacokinetic parameters", "12 - lead electrocardiography and routine laboratory test ( blood biochemistry", "breakthrough bleeding", "pharmacokinetic", "Asymptomatic urinary infections", "Vital signs ( blood pressure and heart rate )", "hepatitis B , hepatitis C and HIV serology , drug abuse urinary test and pregnancy test .", "menstrual disorders", "Dilution integrity and matrix selectivity", "Plasma concentration values", "tmax", "3 -", "dysmenorrhoeas", "Cmax", "Adverse events", "between - run accuracy", "Cmax and ( AUC0 \u2013 t", "inhibition of ovulation", "adverse events", "area under the curve from time 0 to the last measurable concentration ( AUC0 \u2013 t ), the area under the curve from time 0 to infinity ( AUC0 \u2013\u221e), maximum plasma concentration ( Cmax ), time to maximum plasma concentration ( tmax ) and terminal elimination half - life ( t1 / 2 ).", "blood levels"]}